Model Study Using SNTEMP for 2000 and 2001 Sample Clauses

Model Study Using SNTEMP for 2000 and 2001. (One-Dimensional Model) Parametrix and TRPA (2002) estimated the effect of the Reservoir on water temperature during the 2001 drought year, using the Stream Network Temperature Model (SNTEMP). Data available prior to model selection and for 2000, which was for years with normal summer flows, indicated little vertical or lateral stratification of the Reservoir (which supported the use of SNTEMP). However, 2001 was a year of extreme low summer flows and significant longitudinal stratification, a difference in temperature from upstream to downstream, was observed in the data. A problem encountered in applying SNTEMP to the Project was related to model reliance on daily time steps with no “carry-over” of heat transport across days. During the low flows in 2001, the daily time step did not adequately represent the transfer of water through the Reservoir. For low flow years, such as 2001, different models such as CE-QUAL-W2, MASS 1 or MASS 2 (Modular Aquatic Simulation System 1D and 2D) were determined to be better predictors of quantitative temperature changes as a result of the project. To compensate for the low flows in 2001, the SNTEMP model was adapted to these conditions by treating the Reservoir as three separate stream segments. In the process of calibrating the SNTEMP model, the simulated temperatures under the measured climatological and hydrological conditions in 2001 were as expected for the upper portion of the Reservoir (Xxxxx Bridge), but time lags of one day in the middle of the Reservoir (Daroga Park) and two days at Rocky Reach Dam were observed. To determine the cause of this time lag, Chelan PUD applied the FloodWav model to Reservoir in 2001 to determine water travel times. FloodWav, maintained by the National Weather Service, computes water travel times in a depth and width- averaged manner (i.e., one-dimensional, plus-time scale), and predicted travel time from Xxxxx Dam under the average 2001 study period flow of 60,000 cfs (extreme drought conditions). The predicted water travel times from Xxxxx Dam were 0.44 days to Xxxxx Bridge, 1.56 days to Daroga Park, and 3.51 days to Rocky Reach Dam. This simulated delay in water movement within the Reservoir generally matched the downstream temperature data recorded by the installed thermographs. This water travel time information was used to modify the study by segmenting the Reservoir into three sections. This effort partially compensated for the one-dimensional limitations of the SNTEMP model. ...
Sample 1
AutoNDA by SimpleDocs

Related to Model Study Using SNTEMP for 2000 and 2001

  • Feasibility Study Buyer will, at Buyer's expense and within ____ days from Effective Date ("Feasibility Study Period"), determine whether the Property is suitable, in Buyer's sole and absolute discretion, for ___________________ use. During the Feasibility Study Period, Buyer may conduct a Phase I environmental assessment and any other tests, analyses, surveys and investigations ("Inspections") that Buyer deems necessary to determine to Buyer's satisfaction the Property's engineering, architectural and environmental properties; zoning and zoning restrictions; subdivision statutes; soil and grade; availability of access public roads, water, and other utilities; consistency with local, state and regional growth management plans, availability of permits, government approvals, and licenses; and other inspections that Buyer deems appropriate to determine the Property's suitability for the Buyer's intended use. If the Property must be rezoned, Buyer will obtain the rezoning from the appropriatx xxxernment agencies. Seller will sign all documents Buyer is required to file in connection with development or rezoning approvals. Seller gives Buyer, its agents, contractors and assigns, the right to enter the Property at any time during the Feasibility Study Period for the purpose of conducting inspections; provided, however, that Buyer, its agents, contractors and assigns enter the Property and conduct inspections at their own risk. Buyer will indemnify and hold Seller harmless from xxxxes, damages, costs, claims and expenses of any nature, including attorney's fees, expenses and liability incurred in application for rezoning or related proceedings, and from liability to any person, arising from the conduct of any and all inspections of any work authorized by Buyer. Buyer will not engage in any activity that xxxxx result in a construction lien being filed against the Property without Seller's prior written consent. If this transaction does not close, Buyer will, at Buyer's expense, (1) repair all damages to the Property resulting from the Inspections and return the Property to the condition it was in prior to conduct of the Inspections, and (2) release to Seller all reports and other work generated as a result of the Inspections. Buyer will deliver written notice to Seller prior to the expiration of the Feasibility Study Period of Buyer's determination of whether or not the Properxx xx acceptable. Buyer's failure to comply with this notice requirement will constitute acceptance of the Property as suitable for Buyer's intended use in its "as is" condition. If the Property is unacceptable to Buyer and written notice of this fact is timely delivered to Seller, this Contract will be deemed terminated as of the day after the Feasibility Study period ends and Buyer's deposit(s) will be returned after Escrow Axxxx receives proper authorization form all interested parties.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Additional Information for Product Development Projects Outcome of product development efforts, such copyrights and license agreements. • Units sold or projected to be sold in California and outside of California. • Total annual sales or projected annual sales (in dollars) of products developed under the Agreement. • Investment dollars/follow-on private funding as a result of Energy Commission funding. • Patent numbers and applications, along with dates and brief descriptions.  Additional Information for Product Demonstrations: • Outcome of demonstrations and status of technology. • Number of similar installations. • Jobs created/retained as a result of the Agreement.

  • Annual Production Program document describing the forecasts for Production and handling of Oil, Gas, water, special fluids, and waste arising from the Production process of each Development Area or Field.

  • Budget Impact The rental fee provided for in the agreement is for One Hundred Seventy dollars ($170.00) per month. This is a total annual airport revenue of $2,040.00.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • CFR 200 328. Failure to submit such required Performance Reports may cause a delay or suspension of funding. 30 ILCS 705/1 et seq.

  • Trials The Ship shall run the following test and trials:

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!